NO932148D0 - Fusjonspolypeptider - Google Patents
FusjonspolypeptiderInfo
- Publication number
- NO932148D0 NO932148D0 NO932148A NO932148A NO932148D0 NO 932148 D0 NO932148 D0 NO 932148D0 NO 932148 A NO932148 A NO 932148A NO 932148 A NO932148 A NO 932148A NO 932148 D0 NO932148 D0 NO 932148D0
- Authority
- NO
- Norway
- Prior art keywords
- fusion polypeptides
- polypeptides
- fusion
- Prior art date
Links
- 230000004927 fusion Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62672790A | 1990-12-13 | 1990-12-13 | |
PCT/US1991/009152 WO1992010576A1 (en) | 1990-12-13 | 1991-12-12 | Fusion polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
NO932148D0 true NO932148D0 (no) | 1993-06-11 |
NO932148L NO932148L (no) | 1993-08-09 |
Family
ID=24511577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO93932148A NO932148L (no) | 1990-12-13 | 1993-06-11 | Fusjonspolypeptider |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0561971A1 (no) |
JP (1) | JPH06503473A (no) |
AU (1) | AU662508B2 (no) |
CA (1) | CA2094512A1 (no) |
CZ (1) | CZ109393A3 (no) |
FI (1) | FI932680A (no) |
HU (1) | HUT69963A (no) |
IE (1) | IE914347A1 (no) |
NO (1) | NO932148L (no) |
RU (1) | RU2114119C1 (no) |
SK (1) | SK60893A3 (no) |
TW (1) | TW213923B (no) |
WO (1) | WO1992010576A1 (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050272652A1 (en) | 1999-03-29 | 2005-12-08 | Gault Victor A | Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity |
JP2000350590A (ja) * | 1999-04-12 | 2000-12-19 | Pfizer Prod Inc | 成長ホルモン及び成長ホルモン放出ホルモン組成物 |
US6759393B1 (en) | 1999-04-12 | 2004-07-06 | Pfizer Inc. | Growth hormone and growth hormone releasing hormone compositions |
US7229793B1 (en) | 1999-11-19 | 2007-06-12 | Shire Human Genetic Therapies, Inc. | Constructs and cells for production of small peptides |
EP1205551A1 (en) * | 2000-11-09 | 2002-05-15 | Pfizer Products Inc. | Growth hormone and growth hormone releasing hormone compositions |
EP2298337B1 (en) | 2003-12-09 | 2017-02-22 | Novo Nordisk A/S | Regulation of food preference using GLP-1 agonists |
WO2005120492A1 (en) | 2004-06-11 | 2005-12-22 | Novo Nordisk A/S | Counteracting drug-induced obesity using glp-1 agonists |
US8263545B2 (en) | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
EA011653B1 (ru) | 2005-02-11 | 2009-04-28 | Амилин Фармасьютикалз, Инк. | Аналоги и гибридные полипептиды gip с избираемыми свойствами |
US7855279B2 (en) | 2005-09-27 | 2010-12-21 | Amunix Operating, Inc. | Unstructured recombinant polymers and uses thereof |
EP1996220B2 (en) † | 2006-03-06 | 2023-08-16 | Amunix Operating Inc. | Unstructured recombinant polymers and uses thereof |
US8497240B2 (en) | 2006-08-17 | 2013-07-30 | Amylin Pharmaceuticals, Llc | DPP-IV resistant GIP hybrid polypeptides with selectable properties |
DK3178835T3 (da) | 2009-02-03 | 2019-06-24 | Amunix Pharmaceuticals Inc | Forlængede rekombinante polypeptider og sammensætninger omfattende samme |
US20110046060A1 (en) | 2009-08-24 | 2011-02-24 | Amunix Operating, Inc., | Coagulation factor IX compositions and methods of making and using same |
EP2573102B1 (en) * | 2010-01-29 | 2018-10-03 | Archer-Daniels-Midland Company | Peptide domains that bind small molecules of industrial significance |
AU2013204636B2 (en) | 2012-02-15 | 2016-04-14 | Bioverativ Therapeutics Inc. | Recombinant Factor VIII proteins |
BR112014020694A2 (pt) | 2012-02-15 | 2018-05-08 | Amunix Operating Inc. | proteína de fusão do fator viii compreendendo polipeptídeo do fator viii fusionado a polipeptí-deo recombinante estendido (xten) e seu método de fabricação, ácido nucleico, vetores, célula hospedeira, bem como composição farmacêutica e seu uso no tratamento de coagulopatia, episódio de hemorragia e hemofilia a |
TWI667255B (zh) | 2013-08-14 | 2019-08-01 | 美商生物化學醫療公司 | 因子viii-xten融合物及其用途 |
TWI741992B (zh) | 2015-08-03 | 2021-10-11 | 美商百歐維拉提夫治療公司 | 因子ix融合蛋白以及其製備及使用方法 |
EP3645558A2 (en) * | 2017-06-29 | 2020-05-06 | UREKA Sarl | Pro-drug peptide with improved pharmaceutical properties |
MX2020012397A (es) | 2018-05-18 | 2021-04-12 | Bioverativ Therapeutics Inc | Metodos de tratamiento de la hemofilia a. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4703004A (en) * | 1984-01-24 | 1987-10-27 | Immunex Corporation | Synthesis of protein with an identification peptide |
US4569794A (en) * | 1984-12-05 | 1986-02-11 | Eli Lilly And Company | Process for purifying proteins and compounds useful in such process |
CA1340522C (en) * | 1987-03-10 | 1999-05-04 | Heinz Dobeli | Fusion proteins containing neighbouring histidines for improved purification |
AU625787B2 (en) * | 1989-06-16 | 1992-07-16 | Pharmacia & Upjohn Company | Stabilized, potent grf analogs |
ATE139572T1 (de) * | 1990-04-09 | 1996-07-15 | Upjohn Co | Verfahren zur reinigung von rekombinanten proteinen und dafür nützliche produkte |
-
1991
- 1991-12-12 CA CA002094512A patent/CA2094512A1/en not_active Abandoned
- 1991-12-12 RU RU93045577A patent/RU2114119C1/ru active
- 1991-12-12 AU AU91165/91A patent/AU662508B2/en not_active Ceased
- 1991-12-12 EP EP92901817A patent/EP0561971A1/en not_active Withdrawn
- 1991-12-12 WO PCT/US1991/009152 patent/WO1992010576A1/en not_active Application Discontinuation
- 1991-12-12 SK SK60893A patent/SK60893A3/sk unknown
- 1991-12-12 JP JP4501996A patent/JPH06503473A/ja active Pending
- 1991-12-12 HU HU9301705A patent/HUT69963A/hu unknown
- 1991-12-12 CZ CS931093A patent/CZ109393A3/cs unknown
- 1991-12-13 IE IE434791A patent/IE914347A1/en not_active Application Discontinuation
- 1991-12-17 TW TW080109839A patent/TW213923B/zh active
-
1993
- 1993-06-11 FI FI932680A patent/FI932680A/fi not_active Application Discontinuation
- 1993-06-11 NO NO93932148A patent/NO932148L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CZ109393A3 (en) | 1994-01-19 |
NO932148L (no) | 1993-08-09 |
JPH06503473A (ja) | 1994-04-21 |
WO1992010576A1 (en) | 1992-06-25 |
AU9116591A (en) | 1992-07-08 |
HUT69963A (en) | 1995-09-28 |
SK60893A3 (en) | 1993-10-06 |
IE914347A1 (en) | 1992-06-17 |
HU9301705D0 (en) | 1993-10-28 |
CA2094512A1 (en) | 1992-06-14 |
AU662508B2 (en) | 1995-09-07 |
RU2114119C1 (ru) | 1998-06-27 |
FI932680A0 (fi) | 1993-06-11 |
FI932680A (fi) | 1993-06-11 |
TW213923B (no) | 1993-10-01 |
EP0561971A1 (en) | 1993-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG94328A (bg) | Полипептиди | |
ATA150090A (de) | Hoergeraet | |
NO932148D0 (no) | Fusjonspolypeptider | |
DK162890D0 (da) | Polypeptid | |
NO983400D0 (no) | Oppfiskingsverkt°y | |
FR2650644B1 (fr) | Joint homocinetique | |
DE69329145D1 (de) | Anti-virale Fusionspeptide | |
ITMI912631A1 (it) | Giunto cardanico | |
DE69120700D1 (de) | Polypeptidepaar | |
ATA210290A (de) | Lotpille | |
DK284489D0 (da) | Fusionsproteiner | |
ATA80690A (de) | Alpinschi | |
KR920008084U (ko) | 이음매 | |
IT1243098B (it) | Giunto | |
ATA200090A (de) | Pianino | |
FI930108A0 (fi) | Imidazopyridin-paf-antagonister | |
KR910020454U (ko) | 이음관 | |
ATA237490A (de) | Rinnenstein | |
ATA209290A (de) | Diaraehmchen | |
NO923573D0 (no) | Syntetiske polypeptider | |
KR910018223U (ko) | 조립용기 | |
KR910018928U (ko) | 퓨우즈 | |
FR2649773B1 (fr) | Joint imperdable | |
DK106390D0 (da) | Polypeptid | |
DK185590D0 (da) | Polypeptid |